Azelaic Acid & Bakuchiol
— Gentle Pigmentation Correction Without Photosensitization
Why azelaic acid and bakuchiol are among the most photostable depigmentation strategies for the morning routine – and what science says about the combination of these active ingredients.
Azelaic acid and bakuchiol are among the most scientifically discussed active ingredients in current depigmentation research – and both share a property that distinguishes them from classic brightening strategies: they are considered low in photosensitization, which makes their application in the morning conceptually attractive within a narrow time window. Especially for users who rely on efficiency in their routine, the question arises whether this combination is dermatologically plausible.
The literature shows increasingly nuanced findings: azelaic acid inhibits tyrosinase and possesses antioxidant and mildly keratolytic properties without creating the increased UV sensitivity typical of glycolic acid or retinol. Bakuchiol, on the other hand – the plant-based meroterpene phenol from Psoralea corylifolia – can modulate retinoid-like gene expression patterns without the photolabile molecular structure of classic retinoids. The combination of both active ingredients in a morning routine is therefore not only temporally but also mechanistically debatable.
Tyrosinase blockade, retinoid mimicry, and why no photosensitization signal is created
To understand why this combination can work in the morning, three levels of mechanism must be considered separately: the enzymatic inhibition of melanogenesis, the transcriptional effect of bakuchiol, and the molecular reason for the absence of UV hypersensitization.
Azelaic acid (nonanedioic acid) competitively inhibits tyrosinase, the key enzyme of melanin synthesis, and exhibits structural selectivity: It preferentially acts on hyperactive melanocytes, while normopigmented cells are less affected. Mechanistically, the dicarboxyl structure of the acid competes with L-DOPA for the active copper center of the enzyme. At the same time, azelaic acid has a mild antiproliferative effect on melanocytes and can be associated in the literature with a reduction in abnormal melanosome distribution – without the cytotoxic side effects typical of hydroquinone.
Bakuchiol is not structurally a retinoid, but according to the current body of evidence, it can activate RARα and RARγ receptors as well as regulate retinoic acid-responsive genes – including COL1A1, MMP1, and TIMP1 – in a comparable manner. Since bakuchiol does not have a conjugated polyene chain that absorbs photons in the UVA/UVB range, the primary mechanism through which classic retinol leads to UV hypersensitization is absent. This explains why bakuchiol shows high UV stability in photostability studies and is discussed in the professional literature as a morning-suitable retinoid mimic.
While azelaic acid primarily acts enzymatically on tyrosinase, bakuchiol intervenes at the transcriptional level in processes that influence collagen remodeling and indirectly the skin structure – both factors that can be relevant for the visual perception of hyperpigmentation. The combination thus addresses complementary steps of the melanogenic cascade: enzymatic inhibition plus structural support. In the literature, it is increasingly discussed whether such active ingredient combinations could go beyond additive effects, although robust clinical data on the combination of both substances are still lacking.
Four pigmentation situations – and how azelaic acid and bakuchiol are each categorized
Azelaic acid and bakuchiol address pigmentation in complementary ways – enzymatically and transcriptionally – and share favorable photostability, which supports their use in the morning. Their combination is not a quick promise, but a consistent long-term concept: Only after 8–12 weeks of regular application are reproducible improvements described in the professional literature. Sun protection remains an independent, non-substitutable measure.
Application sequence, sun protection, and what really makes the routine work
- Place azelaic acid and bakuchiol separately from SPF in the layering order (active ingredient before sunscreen)
- Introduce gradually – first one of the two active ingredients, then add the second
- SPF 30–50 as a non-negotiable measure, regardless of the choice of active ingredients
- Moisture support through barrier-strengthening active ingredients (e.g., Ceramides) as a buffer for sensitive skin
- Consistent application for at least 8–12 weeks to assess effectiveness
- Simultaneous application with highly keratolytic AHAs in the morning – increased risk of irritation
- Omitting sun protection under the assumption that low-photosensitizing active ingredients provide sufficient protection
- Overdosing through multiple brightening active ingredients in a single routine (e.g., additionally Arbutin in a high concentration)
- Neglecting barrier care while simultaneously performing active evening exfoliation
The Porcelain Skin Serum accompanies the morning rhythm with an active ingredient profile focused on moisture retention, barrier function, and skin structure – formulated with pullulan, two forms of hyaluronic acid, Kigelia extract, amino acid-based active ingredients, functional silk polypeptides, and licorice root extract. It contains neither azelaic acid nor bakuchiol, but can be integrated into such a morning routine as a moisture-retaining layer before sun protection. For the evening, the Chrono-Barrier Skin Science™ logic relies on a separate nighttime rhythm: The Blue Crystal Drops face oil works with bioactive phytosterols, vitamin C, bisabolol, as well as essential oils from blue lotus and blue lotus root, and is focused on nighttime regeneration, antioxidant protection, and a protective film – a supplement that can pick up the regeneration impulse partly required after bakuchiol and azelaic acid in the evening, without competing with the pigmentation-oriented morning routine.
For specific skin concerns – such as persistent irritation or treatment-resistant pigmentation like melasma – a professional medical assessment should be sought.
Frequently Asked Questions
Can I use azelaic acid and bakuchiol together in a single texture, or should they be applied separately?
Both active ingredients are fundamentally compatible in combined formulations, as they complement each other in their mode of action and show no known antagonistic interactions. In practice, separate application – for example, azelaic acid as a serum, followed by bakuchiol in an emulsion – can facilitate individual dosage control. Ready-made combination products simplify the routine to 60 seconds, but require that both active ingredients are present in a stable concentration and compatible pH range (ideally pH 4–5 for azelaic acid).
Is bakuchiol really photostable, or do I still have to apply it in the evening?
Bakuchiol shows high UV stability in photostability studies according to ICH Q1B and thus differs fundamentally from retinol, which oxidizes into reactive degradation products under UV exposure. Nevertheless, bakuchiol does not replace sun protection in the morning, as it itself has no UV filtering properties. For users who prefer it in the evening, the benefit of a longer contact time with the skin without UV interruption speaks for itself – both are possible, as long as SPF is applied in the morning regardless. Further information on this can be found in the Bakuchiol Basics Article.
What about the combination of azelaic acid and other brightening active ingredients such as arbutin or vitamin C?
The simultaneous application of multiple tyrosinase inhibitors – such as azelaic acid, arbutin, and vitamin C – is discussed in the literature as potentially synergistic, but also carries the risk of cumulative overtreatment, especially for sensitive skin. A gradual combination, where the tolerance of each active ingredient is first tested individually, is preferable to the simultaneous introduction of all substances. In addition, the total amount of brightening active ingredients in a single routine should remain focused on one mode of action to minimize irritation.
How long does it take for azelaic acid and bakuchiol to show visible results?
Controlled studies describe reproducible improvements in pigmentation after 4–12 weeks for azelaic acid and approximately 12 weeks for bakuchiol. Neither active ingredient works acutely; instead, they act through cell cycles and enzymatic processes that take time. The most common reason for perceived ineffectiveness is a treatment period that is too short combined with a lack of UV protection. The article on Arbutin and Tyrosinase Inhibition also provides a clinically oriented overview of this, highlighting related mechanisms.
- Draelos, Z.D. (2007). Skin lightening preparations and the hydroquinone controversy. Dermatologic Therapy, 20(5), 308–313.
- Dhaliwal, S., Rybak, I., Ellis, S.R., et al. (2019). Prospective, randomized, double-blind assessment of topical bakuchiol and retinol for facial photoageing. British Journal of Dermatology, 180(2), 289–296.
- Breathnach, A.S. (1996). Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies. Cutis, 57(1 Suppl), 36–45.
- Chaudhuri, R.K. & Bojanowski, K. (2014). Bakuchiol: a retinol-like functional compound revealed by gene expression profiling and clinically proven to have anti-aging effects. International Journal of Cosmetic Science, 36(3), 221–230.
- Nazzaro-Porro, M. (1987). Azelaic acid. Journal of the American Academy of Dermatology, 17(6), 1033–1041.
This article is for informational purposes only and does not constitute medical advice. For specific skin concerns, we recommend consulting a dermatologist.
